Identification of Neutrophil Extracellular Trap-Related Gene Expression Signatures in Ischemia Reperfusion Injury During Lung Transplantation: A Transcriptome Analysis and Clinical Validation
Jiameng Gao,Zhiyuan Zhang,Jing Yu,Nan Zhang,Yu Fu,Xuemei Jiang,Zheyu Xia,Qingqing Zhang,Zongmei Wen
DOI: https://doi.org/10.2147/jir.s444774
IF: 4.5
2024-02-13
Journal of Inflammation Research
Abstract:Jiameng Gao, 1, 2, &ast Zhiyuan Zhang, 1, 2, &ast Jing Yu, 1, 2, &ast Nan Zhang, 1, 2 Yu Fu, 1, 2 Xuemei Jiang, 1, 2 Zheyu Xia, 3 Qingqing Zhang, 1, 2 Zongmei Wen 1, 2 1 Department of Anesthesiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China; 2 Shanghai Engineering Research Center of Lung Transplantation, Shanghai, People's Republic of China; 3 School of Medicine, Tongji University, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zongmei Wen; Qingqing Zhang, Department of Anesthesiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, 507 Zhengmin Road, Shanghai, 200433, People's Republic of China, Tel +86 13761635280 ; +86 13764542055, Email ; Purpose: Ischemia reperfusion injury (IRI) unavoidably occurs during lung transplantation, further contributing to primary graft dysfunction (PGD). Neutrophils are the end effectors of IRI and activated neutrophils release neutrophil extracellular traps (NETs) to further amplify damage. Nevertheless, potential contributions of NETs in IRI remain incompletely understood. This study aimed to explore NET-related gene biomarkers in IRI during lung transplantation. Methods: Differential expression analysis was applied to identify differentially expressed genes (DEGs) for IRI during lung transplantation based on matrix data (GSE145989, 127003) downloaded from GEO database. The CIBERSORT and weighted gene co-expression network analysis (WGCNA) algorithms were utilized to identify key modules associated with neutrophil infiltration. Moreover, the least absolute shrinkage and selection operator regression and random forest were applied to identify potential NET-associated hub genes. Subsequently, the screened hub genes underwent further validation of an external dataset (GSE18995) and nomogram model. Based on clinical peripheral blood samples, immunofluorescence staining and dsDNA quantification were used to assess NET formation, and ELISA was applied to validate the expression of hub genes. Results: Thirty-eight genes resulted from the intersection between 586 DEGs and 75 brown module genes, primarily enriched in leukocyte migration and NETs formation. Subsequently, four candidate hub genes (FCAR, MMP9, PADI4, and S100A12) were screened out via machine learning algorithms. Validation using an external dataset and nomogram model achieved better predictive value. Substantial NETs formation was demonstrated in IRI, with more pronounced NETs observed in patients with PGD ≥ 2. PADI4, S100A12, and MMP9 were all confirmed to be up-regulated after reperfusion through ELISA, with higher levels of S100A12 in PGD ≥ 2 patients compared with non-PGD patients. Conclusion: We identified three potential NET-related biomarkers for IRI that provide new insights into early detection and potential therapeutic targets of IRI and PGD after lung transplantation. Keywords: ischemia reperfusion injury, neutrophil extracellular traps, lung transplantation, primary graft dysfunction, WGCNA, machine learning Lung transplantation has been established worldwide as the only effective remedy for end-stage lung diseases, including chronic obstructive pulmonary disease, interstitial lung disease, cystic fibrosis. 1,2 Over the past few decades, the field of lung transplantation has witnessed remarkable advances, experiencing a substantial surge in lung transplantation procedures since the first successful operation in 1983. 3 Annually, over 4000 lung transplantations are conducted worldwide. 4 Despite, morbidity and mortality of lung transplant patients remain high compared with other solid organ transplants. IRI is an unavoidable occurrence following lung transplantation, which characterized by uncontrolled sterile inflammation, increased microvascular permeability, elevated pulmonary vascular resistance, pulmonary edema, impaired oxygenation, and pulmonary hypertension. 5–7 And it is the main mechanism of primary graft dysfunction (PGD), one of the major clinical challenges for clinicians in the perioperative period of lung transplantation as well as a leading cause of early allograft failure. 8,9 Since the exact underlying pathogenesis of IRI during lung transplantation remains unclear and the absence of effective therapies, further investigation is warranted to explore targeted treatments aimed at the pathogenetically altered expressed genes associated with IRI and PGD. Neutrophils a -Abstract Truncated-
immunology